Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05636800 · ClinicalTrials.gov registry record · NA
Microwave Treatment for Actinic Keratosis
A NA study of Keratosis, Actinic, sponsored by Blackwell Device Consulting.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT05636800: Active NA study of Keratosis, Actinic, sponsored by Blackwell Device Consulting.
NCT05636800 is a NA study of Keratosis, Actinic that is active but no longer recruiting, run by Blackwell Device Consulting. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05636800, a NA study of Keratosis, Actinic, is active but no longer recruiting, sponsored by Blackwell Device Consulting.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a randomized, controlled, multi-center trial in subjects diagnosed with Actinic Keratosis (AK) where each subject serves as their own control. The trial will be conducted at 2 sites, one in Germany and one in the United States. Approximately 60 subjects will be randomized to ensure 51 subjects complete the study.
Conditions Studied
Interventions
- DEVICE Swift System
Study Locations (2)
Florida
- Miami Dermatology and Laser Institute - Miami
Other
- Centroderm GmbH - Wuppertal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
What the registry record for NCT05636800 still lists
NCT05636800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Keratosis, Actinic appearing as the primary indexed condition, and to 1 intervention - of which Swift System is the first listed.
NCT05636800 reports a single indexed study location in Florida, Other.
Frequently Asked Questions
What is clinical trial NCT05636800 about?
NCT05636800 is a clinical study titled "Microwave Treatment for Actinic Keratosis". This is a randomized, controlled, multi-center trial in subjects diagnosed with Actinic Keratosis (AK) where each subject serves as their own control. The trial will be conducted at 2 sites, one in Germany and one in the United States. Approximately 60 subjects will be randomized to ensure 51 subjec...
What is the current status of trial NCT05636800?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-01-18. Estimated completion is 2024-11-01.
What conditions does trial NCT05636800 study?
This clinical trial studies the following conditions: Keratosis, Actinic.
What interventions are being tested in trial NCT05636800?
The interventions under investigation include: Swift System (DEVICE).
Who is sponsoring clinical trial NCT05636800?
This trial is sponsored by Blackwell Device Consulting, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05636800 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratosis, Actinic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05636800's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI